After the hot holiday weekend, it's difficult to imagine a future when we'll be wishing for warm weather. That said, November is the perfect time to visit Arizona. Have you already made plans to attend SHSA 2026 in Tucson?

For the first time, we're hosting a full day of events on Friday, November 6, including two procedural workshops, a collaborative research workshop, two timely plenaries, and more. Take a moment to browse the agenda for details on speakers, topics, and programming.

REGISTER NOW

As you finalize your plans, keep a few important dates in mind: abstracts are due July 27, and discounted early-bird registration ends August 20. July 27 is also when we start accepting applications to HS Academy, our free educational program for dermatology residents. Please share this opportunity with any residents who may be interested.

Thank you for being part of the HS community and for your continued passion, curiosity, and commitment to advancing care.

NEW RESOURCES

RESEARCH

Improve the lives of children & adolescents with HS & apply by 7/30 for PeDRA's

Pediatric HS Challenge Grant.

EDUCATION

Gain vital HS guidance from pediatricians, gynecologists, ER docs & more in these

Provider Education Videos.

ADVOCACY

Reduce barriers to SHSA & apply for one of our NEW funding opportunities:

Patient Scholarships &

Social Media Ambassador.

RECENT PUBLICATIONS

HOW TO TREAT HS

Discover how the new HS clinical guidelines will impact patient care

HS Foundation CEO, Brent Hazelett, explores how traditional standards are struggling to keep up with HS & why new, patient-centered approaches are now gaining traction. Discover how the field is beginning to close the gap between outdated guidelines & real-world care.

Learn more & follow updates at HowToTreatHS.com.

VIDEOS

Explore how HSF supports investigators

Hear from investigators conducting new clinical & translational research in HS at all career stages:

Drs. Yaghi & Mandel explain how their pilot study measuring functional impairment in HS patients has real world impacts across disciplines
Tammy Gonzalez, MD, PhD discusses her research into the microbiome, anaerobes & inflammation in HS & how putting patients first is a priority

Watch these other educational videos at www.hs-foundation.org/news.

IN THE NEWS

Browse recent articles showcasing HS

A potential new chapter in HS treatment is unfolding with povorcitinib, an oral JAK1-selective inhibitor showing promising phase 3 results. With generally favorable tolerability & once-daily dosing, povorcitinib could help address gaps in HS care & expand options beyond injectable biologics.

Read this & other recent news at www.hs-foundation.org/news.